13D/13G Filings - Innate Pharma SA (IPHA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-07
4:02 pm
Purchase
2025-04-2513DInnate Pharma S.A.
IPHA
Bpifrance Participations S.A.7,319,429
7.900%
132,801increase
(+1.85%)
Filing
History
2025-04-29
6:48 pm
Unchanged
2025-04-2313GInnate Pharma S.A.
IPHA
Sanofi8,345,387
9.050%
0
(Unchanged)
Filing
History
2025-04-29
2:08 pm
Purchase
2025-04-2313GInnate Pharma S.A.
IPHA
Sanofi8,345,387
9.050%
8,345,387increase
(New Position)
Filing
History
2022-12-06
11:52 am
Sale
2022-11-2313DInnate Pharma S.A.
IPHA
Bpifrance Participations S.A.7,186,628
9.000%
-801,741decrease
(-10.04%)
Filing
History
2022-10-21
12:58 pm
Sale
2022-10-1113DInnate Pharma S.A.
IPHA
Bpifrance Participations S.A.7,988,369
10.000%
-964,098decrease
(-10.77%)
Filing
History
2021-02-12
2:35 pm
Purchase
2021-02-1213DInnate Pharma S.A.
IPHA
Bpifrance Participations S.A.8,952,467
11.300%
8,952,467increase
(New Position)
Filing
History